ARS Pharmaceuticals (SPRY) Shares Issued (2021 - 2025)
Historic Shares Issued for ARS Pharmaceuticals (SPRY) over the last 5 years, with Q3 2025 value amounting to $479000.0.
- ARS Pharmaceuticals' Shares Issued fell 2955.88% to $479000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 6526.76%. This contributed to the annual value of $3.0 million for FY2024, which is 5628.35% down from last year.
- Latest data reveals that ARS Pharmaceuticals reported Shares Issued of $479000.0 as of Q3 2025, which was down 2955.88% from $2.7 million recorded in Q2 2025.
- ARS Pharmaceuticals' Shares Issued's 5-year high stood at $2.9 million during Q2 2023, with a 5-year trough of -$1.0 million in Q4 2021.
- In the last 5 years, ARS Pharmaceuticals' Shares Issued had a median value of $680000.0 in 2024 and averaged $856176.5.
- As far as peak fluctuations go, ARS Pharmaceuticals' Shares Issued surged by 89442.51% in 2023, and later plummeted by 8090.4% in 2024.
- Quarter analysis of 5 years shows ARS Pharmaceuticals' Shares Issued stood at -$1.0 million in 2021, then soared by 127.85% to $283000.0 in 2022, then soared by 537.81% to $1.8 million in 2023, then decreased by 15.07% to $1.5 million in 2024, then plummeted by 68.75% to $479000.0 in 2025.
- Its Shares Issued stands at $479000.0 for Q3 2025, versus $2.7 million for Q2 2025 and $725000.0 for Q1 2025.